Skip to main
We’re doing some system maintenance
  1. /
  2. Stocks
  3. /
  4. Chimerix
CMRX

Buy Chimerix (CMRX) Stock

CMRX
See CMRX stock price and Buy/Sell Chimerix with any amount of money. Discuss news and analysts' price predictions with the investor community.
Sign up to start investing
CMRX

Chimerix (CMRX)

About Chimerix (CMRX)

Chimerix, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of pharmaceutical products. Its portfolio includes Brincidofovir for the treatment of adenovirus, cytomegalovirus, and smallpox. The company was founded by George R. Painter, III and Timothy Wollaeger in April 2000 and is headquartered in Durham, NC.
Market Cap
$158.6M
1 Year High
$7.42
Volume
525.33k
1 Year Low
$1.27
Price to Earnings Ratio
Open
$1.80
Dividend Rate
High
$1.91
Dividend Yield
Low
$1.80

Community

People who own or watch CMRX stock

Chimerix Price Targets

What analysts think CMRX stock price will be.
$1.81
$7.50
314.4% Upside
$1$8

Chimerix Stock Rating

What analysts recommend for CMRX stock, on a scale from 1(buy) to 5(sell).
Strong Buy1.2 / 5
BuyHoldSell

Chimerix Stock Earnings

The value each CMRX share was expected to gain vs. the value that each CMRX share actually gained.
Expected
Actual

Chimerix Stock News

Frequently Asked Questions (FAQ)

As of Sep 26, 2022, the market cap for Chimerix stock is $158.6M

The 52-week high for Chimerix stock is $7.42. The current Chimerix stock price $1.81 is 75.61% below its 52-week high

The 52-week low for Chimerix stock is $1.27. The current Chimerix stock price $1.81 has increased 29.83% from its 52-week low

No, the Chimerix stock does not pay dividends to its shareholders

The target price for Chimerix stock is $7.50 based on the average of what a group of analyst think Chimerix stock could be worth at a future date. This is not a prediction by Public.com

Buy Chimerix (CMRX) Stock

CMRX
See CMRX stock price and Buy/Sell Chimerix with any amount of money. Discuss news and analysts' price predictions with the investor community.
Sign up to start investing

Community

People who own or watch CMRX stock
  • LaloBarko avatar
  • 345456 avatar
  • Kolisekj52 avatar
  • thendn avatar
  • alaa198354 avatar
Check the background of this firm on FINRA’s BrokerCheck.

© Copyright 2022 Public Holdings, Inc. All Rights Reserved.

Market data powered by Xignite.

Securities are offered to self-directed customers by Open to the Public Investing, Inc. (“Open to the Public Investing”), a registered broker-dealer and member of FINRA & SIPC. Additional information about your broker can be found by clicking here. Open to Public Investing is a wholly-owned subsidiary of Public Holdings Inc. (“Public Holdings”). This is not an offer, solicitation of an offer or advice to buy or sell securities, or open a brokerage account in any jurisdiction where Open to the Public Investing is not registered. Securities products offered by Open to the Public Investing are not FDIC insured.

Cryptocurrency execution and custody services are provided by Apex Crypto LLC (NMLS ID 1828849) through a software licensing agreement between Apex Crypto LLC and Public Crypto LLC. Apex Crypto is not a registered broker-dealer or a member of SIPC or FINRA. Cryptocurrencies are not securities and are not FDIC or SIPC insured. Apex Crypto is licensed to engage in virtual currency business activity by the New York State Department of Financial Services. Please ensure that you fully understand the risks involved before trading: Legal Disclosures

Commission-free trading of stocks and ETFs refers to $0 commissions for Open to the Public Investing self-directed individual cash brokerage accounts that trade the U.S. listed securities electronically. Keep in mind, that other fees such as regulatory fees, Premium subscription fees, wire transfer fees, and paper statement fees may apply to your brokerage account. Please see Open to the Public Investing’s Fee Schedule to learn more.

All investments involve the risk of loss and the past performance of a security or a financial product does not guarantee future results or returns.